Literature DB >> 18033008

Cardiac sodium channel Nav1.5 and its associated proteins.

H Abriel1.   

Abstract

The main cardiac voltage-gated Na+ channel, Nav1.5, plays a key role in generation of the cardiac action potential (cardiac excitability) and propagation of the electrical impulse in the heart (cardiac conduction). During the past decade, numerous mutations in SCN5A, the gene, encoding Nav1.5, were found in patients with different pathologic cardiac phenotypes such as the congenital long QT syndrome type 3, Brugada syndrome, and progressive cardiac conduction defect (or Lenègre-Lev disease). These mutations define a sub-group of Nav1.5 / SCN5A-related cardiac channelopathies. Recent works have suggested that Nav1.5 is part of several multi-protein complexes located in different membrane compartments of the cardiac cells. In some instances, the genes of these regulatory proteins were also found to be mutated in patients with inherited forms of cardiac arrhythmias. The proteins that associate with Nav1.5, and form these complexes, can be classified as 1) anchoring/adaptor proteins, 2) enzymes interacting with and modifying the channel, and 3) proteins modulating the biophysical properties of Nav1.5 upon binding. The purpose of this short article is to review the proposed roles of these interactions. These recent observations indicate that the expression level, cellular localization, and activity of Nav1.5 are finely regulated by complex molecular mechanisms that we are only starting to elucidate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033008

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  6 in total

1.  Targeting ion channels for the treatment of gastrointestinal motility disorders.

Authors:  Arthur Beyder; Gianrico Farrugia
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Localization of sodium channel subtypes in mouse ventricular myocytes using quantitative immunocytochemistry.

Authors:  Ruth E Westenbroek; Sebastian Bischoff; Ying Fu; Sebastian K G Maier; William A Catterall; Todd Scheuer
Journal:  J Mol Cell Cardiol       Date:  2013-08-24       Impact factor: 5.000

3.  Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy.

Authors:  Man Liu; Lianzhi Gu; Matthew S Sulkin; Hong Liu; Euy-Myoung Jeong; Ian Greener; An Xie; Igor R Efimov; Samuel C Dudley
Journal:  J Mol Cell Cardiol       Date:  2012-11-01       Impact factor: 5.000

4.  Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.

Authors:  Gül Erdemli; Albert M Kim; Haisong Ju; Clayton Springer; Robert C Penland; Peter K Hoffmann
Journal:  Front Pharmacol       Date:  2012-01-26       Impact factor: 5.810

Review 5.  Genetics of inherited primary arrhythmia disorders.

Authors:  Danna A Spears; Michael H Gollob
Journal:  Appl Clin Genet       Date:  2015-09-18

6.  A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortality.

Authors:  Xiaoming Zhang; Jin-Young Yoon; Michael Morley; Jared M McLendon; Kranti A Mapuskar; Rebecca Gutmann; Haider Mehdi; Heather L Bloom; Samuel C Dudley; Patrick T Ellinor; Alaa A Shalaby; Raul Weiss; W H Wilson Tang; Christine S Moravec; Madhurmeet Singh; Anne L Taylor; Clyde W Yancy; Arthur M Feldman; Dennis M McNamara; Kaikobad Irani; Douglas R Spitz; Patrick Breheny; Kenneth B Margulies; Barry London; Ryan L Boudreau
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.